{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T06:50:36Z","timestamp":1776322236561,"version":"3.50.1"},"reference-count":76,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Br\u00f6stcancerforbundet","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"R&D Council in Gothenburg and Bohusl\u00e4n","award":["VGFOUGSB-932984"],"award-info":[{"award-number":["VGFOUGSB-932984"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,9,25]]},"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The peRson-cEntred Support Programme EndoCrine Therapy intervention is a complex intervention encompassing a person-centred support programme for patients with breast cancer being treated with endocrine therapy (ET). The aim of this study was to explore the feasibility of the trial design and patient acceptability of the intervention and outcome measures and to provide data to estimate the parameters required to design the final intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A controlled before-and-after design following the Consolidated Standards of Reporting Trials 2010 statement for feasibility trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>A surgical outpatient clinic in Sweden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Forty-one patients (aged 47\u201385) with breast cancer who were treated with ET.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Eligible patients were assigned to the control group or intervention group, which included individual education material, an individualised learning plan and a personalised reminder letter using a person-centred approach. The intervention could be delivered as a telephone or digital follow-up during a 12-week follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>The aims were to determine the recruitment rate, assess the rate of retention, explore whether the intervention was delivered according to the protocol, assess the preferred form of educational support, rate of education sessions, length per education session and length between each education session, determine the distribution of education materials and assess completion rates of patient-reported instruments, including the General Self-efficacy Scale, the Quality of Care from the Patient\u2019s Perspective Questionnaire and the Memorial Symptom Assessment Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighty-six per cent of the patients in the intervention group completed the intervention and questionnaires 3\u2009months after their inclusion. The call attendance was 90%. During the intervention, the contact nurse complied with the intervention protocol. For self-efficacy, symptoms and quality of care, there were no differences in effect size between the control and intervention groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This intervention seems to be feasible and acceptable among patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-060946","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T12:13:17Z","timestamp":1664971997000},"page":"e060946","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Person-centred support programme (RESPECT intervention) for women with breast cancer treated with endocrine therapy: a feasibility study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5436-5476","authenticated-orcid":false,"given":"Susanne","family":"Ahlstedt Karlsson","sequence":"first","affiliation":[{"name":"Health Care Sciences, Sahlgrenska Academy, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingela","family":"Henoch","sequence":"additional","affiliation":[{"name":"Institute of Health and Care Sciences, Gothenburg University, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Olofsson Bagge","sequence":"additional","affiliation":[{"name":"Clinical Sciences, Sahlgrenska Academy, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Wallengren","sequence":"additional","affiliation":[{"name":"Health Care Sciences, Sahlgrenska Academy, Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"2025121514195016000_12.10.e060946.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60993-8"},{"key":"2025121514195016000_12.10.e060946.2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11764-020-00908-5","article-title":"How patients experience endocrine therapy for breast cancer: an online survey of side effects, adherence, and medical team support","volume":"15","author":"Berkowitz","year":"2021","journal-title":"J Cancer Surviv"},{"key":"2025121514195016000_12.10.e060946.3","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/nop2.430","article-title":"Women's coping strategies during the first three months of adjuvant endocrine therapy for breast cancer","volume":"7","author":"Ahlstedt Karlsson","year":"2020","journal-title":"Nurs Open"},{"key":"2025121514195016000_12.10.e060946.4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/0167482X.2016.1216963","article-title":"Factors related to the experience of menopausal symptoms in women prescribed tamoxifen","volume":"38","author":"Moon","year":"2017","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"2025121514195016000_12.10.e060946.5","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejca.2018.03.020","article-title":"Influence of side-effects on early therapy persistence with letrozole in post-menopausal patients with early breast cancer: results of the prospective EvAluate-TM study","volume":"96","author":"Nabieva","year":"2018","journal-title":"Eur J Cancer"},{"key":"2025121514195016000_12.10.e060946.6","doi-asserted-by":"crossref","first-page":"E101","DOI":"10.1188\/17.ONF.E101-E110","article-title":"Deconstructing decisions to initiate, maintain, or discontinue adjuvant endocrine therapy in breast cancer survivors: a mixed-methods study","volume":"44","author":"Bluethmann","year":"2017","journal-title":"Oncol Nurs Forum"},{"key":"2025121514195016000_12.10.e060946.7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10549-020-05748-6","article-title":"Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management","volume":"183","author":"Cavazza","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"2025121514195016000_12.10.e060946.8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/CCI.18.00091","article-title":"Simulating time-dependent patterns of nonadherence by patients with breast cancer to adjuvant oral endocrine therapy","volume":"3","author":"Shinn","year":"2019","journal-title":"JCO Clin Cancer Inform"},{"key":"2025121514195016000_12.10.e060946.9","doi-asserted-by":"crossref","DOI":"10.1097\/CCO.0000000000000781","article-title":"Lifestyle and quality of life in patients with early-stage breast cancer receiving adjuvant endocrine therapy","volume":"33","author":"Di Meglio","year":"2021","journal-title":"Curr Opin Oncol"},{"key":"2025121514195016000_12.10.e060946.10","doi-asserted-by":"crossref","DOI":"10.1016\/j.evalprogplan.2022.102071","article-title":"An intervention mapping-based support program that empowers patients with endocrine therapy management","volume":"92","author":"Ahlstedt Karlsson","year":"2022","journal-title":"Eval Program Plann"},{"key":"2025121514195016000_12.10.e060946.11","first-page":"3329","article-title":"Development of a self-management intervention to improve tamoxifen adherence in breast cancer survivors using an intervention mapping framework","volume":"29","author":"Moon","year":"2021","journal-title":"Support Care Cancer"},{"key":"2025121514195016000_12.10.e060946.12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/NCC.0000000000000641","article-title":"Self-management needs of breast cancer survivors after treatment: results from a focus group interview","volume":"43","author":"Kim","year":"2020","journal-title":"Cancer Nurs"},{"key":"2025121514195016000_12.10.e060946.13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cct.2018.11.010","article-title":"Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (aet)","volume":"76","author":"Shelby","year":"2019","journal-title":"Contemp Clin Trials"},{"key":"2025121514195016000_12.10.e060946.14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.41.8525"},{"key":"2025121514195016000_12.10.e060946.15","article-title":"Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer","volume":"1","author":"Roberts","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121514195016000_12.10.e060946.16","unstructured":"McLauglin Renpenning KT S . G. self-care theory in nursing. In: Selected papers of Dorothea Orem. New York: Springer Publishing Company, 2003."},{"key":"2025121514195016000_12.10.e060946.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1547-5069.2011.01404.x"},{"key":"2025121514195016000_12.10.e060946.18","doi-asserted-by":"publisher","DOI":"10.1177\/089431840101400113"},{"key":"2025121514195016000_12.10.e060946.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcnurse.2011.06.008"},{"key":"2025121514195016000_12.10.e060946.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2009.01214.x"},{"key":"2025121514195016000_12.10.e060946.21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13010107","article-title":"Potentially modifiable factors associated with adherence to adjuvant endocrine therapy among breast cancer survivors: a systematic review","volume":"13","author":"Toivonen","year":"2020","journal-title":"Cancers"},{"key":"2025121514195016000_12.10.e060946.22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/PPA.S126651","article-title":"Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review","volume":"11","author":"Moon","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"2025121514195016000_12.10.e060946.23","unstructured":"Self-efficay BA . The exercise of control. New York: WH Freeman, 1997."},{"key":"2025121514195016000_12.10.e060946.24","doi-asserted-by":"publisher","DOI":"10.1177\/1474515115623437"},{"key":"2025121514195016000_12.10.e060946.25","doi-asserted-by":"crossref","first-page":"927-935","DOI":"10.1002\/nop2.701","article-title":"Effects of person-centred care via telephone on self-efficacy in patients with chronic obstructive pulmonary disease: subgroup analysis of a randomized controlled trial","volume":"8","author":"Ali","year":"2021","journal-title":"Nurs Open"},{"key":"2025121514195016000_12.10.e060946.26","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.4890"},{"key":"2025121514195016000_12.10.e060946.27","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/pon.5341","article-title":"Development of a communication and health literacy curriculum: optimizing the informal cancer caregiver role","volume":"29","author":"Wittenberg","year":"2020","journal-title":"Psychooncology"},{"key":"2025121514195016000_12.10.e060946.28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00006416-199311000-00008","article-title":"Developing and evaluating printed education materials: a prescriptive model for quality","volume":"12","author":"Bernier","year":"1993","journal-title":"Orthop Nurs"},{"key":"2025121514195016000_12.10.e060946.29","doi-asserted-by":"publisher","DOI":"10.1080\/09638280410001724816"},{"key":"2025121514195016000_12.10.e060946.30","unstructured":"Swedish Government Official Reports SOU, (in Swedish) . En nationell cancerstrategi f\u00f6r framtiden; 2009: 11."},{"key":"2025121514195016000_12.10.e060946.31","doi-asserted-by":"crossref","DOI":"10.1590\/1983-1447.2018.2017-0102","article-title":"Role of the nurse navigator: integrative review","volume":"39","author":"Pautasso","year":"2018","journal-title":"Rev Gaucha Enferm"},{"key":"2025121514195016000_12.10.e060946.32","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejon.2019.05.009","article-title":"Patient-reported perceptions of care after the introduction of a new advanced cancer nursing role in Sweden","volume":"41","author":"Westman","year":"2019","journal-title":"Eur J Oncol Nurs"},{"key":"2025121514195016000_12.10.e060946.33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1687"},{"key":"2025121514195016000_12.10.e060946.34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s40814-016-0105-8","article-title":"Consort 2010 statement: extension to randomised pilot and feasibility trials","volume":"2","author":"Eldridge","year":"2016","journal-title":"Pilot Feasibility Stud"},{"key":"2025121514195016000_12.10.e060946.35","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/0017896919853856","article-title":"Acceptability and feasibility of a self-management intervention for women prescribed tamoxifen","volume":"78","author":"Moon","year":"2019","journal-title":"Health Educ J"},{"key":"2025121514195016000_12.10.e060946.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2012.09.010"},{"key":"2025121514195016000_12.10.e060946.37","doi-asserted-by":"publisher","DOI":"10.1177\/1356389018803219"},{"key":"2025121514195016000_12.10.e060946.38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n2061"},{"key":"2025121514195016000_12.10.e060946.39","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g5074"},{"key":"2025121514195016000_12.10.e060946.40","unstructured":"SFS . Patient act; 2014 [Accessed 18 May 2021]."},{"key":"2025121514195016000_12.10.e060946.41","unstructured":"Schober M , Lehwaldt D , Rogers M . Guidelines on advanced practice nursing; 2020."},{"key":"2025121514195016000_12.10.e060946.42","article-title":"Evaluation of the role of the clinical nurse specialist in cancer care: an integrative literature review","volume":"30","author":"Kerr","year":"2021","journal-title":"Eur J Cancer Care"},{"key":"2025121514195016000_12.10.e060946.43","unstructured":"Sjukdomar & besv\u00e4r\/Cancer\/ R\u00e5d och st\u00f6d vid cancerKontaktsjuksk\u00f6terskan \u2013 ditt st\u00f6d i v\u00e5rden vid cancer (21-07-21). Available: http:\/\/www.1177.se"},{"key":"2025121514195016000_12.10.e060946.44","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/fampra\/cmaa060","article-title":"Dumping adherence: a person-centred response for primary care","volume":"37","author":"Granger","year":"2020","journal-title":"Fam Pract"},{"key":"2025121514195016000_12.10.e060946.45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1471-5953(02)00106-3","article-title":"The experiences of lecturers and students in the use of microteaching as a teaching strategy","volume":"3","author":"Higgins","year":"2003","journal-title":"Nurse Educ Pract"},{"key":"2025121514195016000_12.10.e060946.46","first-page":"158","article-title":"Microteaching, an efficient technique for learning effective teaching","volume":"18","author":"Remesh","year":"2013","journal-title":"J Res Med Sci"},{"key":"2025121514195016000_12.10.e060946.47","unstructured":"Dewey J . Democray and education; 2016."},{"key":"2025121514195016000_12.10.e060946.48","unstructured":"Ekman I . Personcentrering inom h\u00e4lso- och sjukv\u00e5rd. Fr\u00e5n filosofi till praktik. In: Liber AB, 2014."},{"key":"2025121514195016000_12.10.e060946.49","unstructured":"Neill GM , McMahon T . Student\u2013centered learning: what does it mean for students and lecturers? In: Emerging issues in the practice of university learning and teaching, 2005."},{"key":"2025121514195016000_12.10.e060946.50","doi-asserted-by":"publisher","DOI":"10.1111\/j..2002.384.doc.x"},{"key":"2025121514195016000_12.10.e060946.51","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s11136-011-0030-5","article-title":"Validation of the Swedish translation of the general self-efficacy scale","volume":"21","author":"L\u00f6ve","year":"2012","journal-title":"Qual Life Res"},{"key":"2025121514195016000_12.10.e060946.52","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jjco\/hyx079","article-title":"Optimism, pessimism and self-efficacy in female cancer patients","volume":"47","author":"Thieme","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"2025121514195016000_12.10.e060946.53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-6712.1993.tb00180.x"},{"key":"2025121514195016000_12.10.e060946.54","doi-asserted-by":"publisher","DOI":"10.1108\/09526860910986867"},{"key":"2025121514195016000_12.10.e060946.55","unstructured":"Wallstr\u00f6m SE , I; Taft C . Svenskarnas syn p\u00e5 personcentrering i v\u00e5rden. SOM-institutets sjuttonde forskarantologi (red Andersson, Ohlsson, Oscarsson och Oskarsson); 2017."},{"key":"2025121514195016000_12.10.e060946.56","unstructured":"Wilde-Larsson B , Larsson G . Reviderat \u00e5tg\u00e4rdsindex. PM 2016:1. Halmstad, Sweden Improveit Digital Solutions AB; 2016."},{"key":"2025121514195016000_12.10.e060946.57","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(94)90182-1"},{"key":"2025121514195016000_12.10.e060946.58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpainsymman.2012.07.023","article-title":"Validity and reliability of the Swedish version of the memorial symptom assessment scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress","volume":"46","author":"Browall","year":"2013","journal-title":"J Pain Symptom Manage"},{"key":"2025121514195016000_12.10.e060946.59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40814-019-0423-8","article-title":"A guide to the reporting of protocols of pilot and feasibility trials","volume":"5","author":"Thabane","year":"2019","journal-title":"Pilot Feasibility Stud"},{"key":"2025121514195016000_12.10.e060946.60","doi-asserted-by":"publisher","DOI":"10.1002\/pst.185"},{"key":"2025121514195016000_12.10.e060946.61","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.12149"},{"key":"2025121514195016000_12.10.e060946.62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150205"},{"key":"2025121514195016000_12.10.e060946.63","doi-asserted-by":"publisher","DOI":"10.1191\/1740774504cn006rr"},{"key":"2025121514195016000_12.10.e060946.64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10549-018-5012-7","article-title":"A systematic review of interventions to improve adherence to endocrine therapy","volume":"173","author":"Heiney","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"2025121514195016000_12.10.e060946.65","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmh704"},{"key":"2025121514195016000_12.10.e060946.66","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7313.625"},{"key":"2025121514195016000_12.10.e060946.67","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1016\/S2589-7500(20)30287-9","article-title":"Digital health during COVID-19: lessons from operationalising new models of care in ophthalmology","volume":"3","author":"Gunasekeran","year":"2021","journal-title":"Lancet Digit Health"},{"key":"2025121514195016000_12.10.e060946.68","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41591-020-1011-4","article-title":"Digital technologies in the public-health response to COVID-19","volume":"26","author":"Budd","year":"2020","journal-title":"Nat Med"},{"key":"2025121514195016000_12.10.e060946.69","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hbe2.242","article-title":"Digital technology use during COVID \u201019 pandemic: A rapid review","volume":"3","author":"Vargo","year":"2021","journal-title":"Hum Behav Emerg Technol"},{"key":"2025121514195016000_12.10.e060946.70","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/nop2.701","article-title":"Effects of person-centred care via telephone on self-efficacy in patients with chronic obstructive pulmonary disease: subgroup analysis of a randomized controlled trial","volume":"8","author":"Ali","year":"2021","journal-title":"Nurs Open"},{"key":"2025121514195016000_12.10.e060946.71","doi-asserted-by":"crossref","DOI":"10.1186\/s12912-020-00448-4","article-title":"Registered nurses' experiences of communication with patients when practising person-centred care over the phone: a qualitative interview study","volume":"19","author":"Bostr\u00f6m","year":"2020","journal-title":"BMC Nurs"},{"key":"2025121514195016000_12.10.e060946.72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.03.336"},{"key":"2025121514195016000_12.10.e060946.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2011.11.010"},{"key":"2025121514195016000_12.10.e060946.74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11764-014-0384-0","article-title":"Cancer survivors' self-efficacy to self-manage in the year following primary treatment","volume":"9","author":"Foster","year":"2015","journal-title":"J Cancer Surviv"},{"key":"2025121514195016000_12.10.e060946.75","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1982.51.2.663"},{"key":"2025121514195016000_12.10.e060946.76","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-4644-7","article-title":"Understanding adjuvant endocrine therapy persistence in breast cancer survivors","volume":"18","author":"Lambert","year":"2018","journal-title":"BMC Cancer"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-060946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:20:01Z","timestamp":1765837201000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-060946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":76,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,5]]},"published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1136\/bmjopen-2022-060946"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-060946","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}